Join our GSK-sponsored scientific sessions on vaccine-preventable diseases

Scientific sessions organised and funded by GSK for healthcare professionals.

GSK products will be discussed.

Saturday 27 - Monday 29 April

Join our GSK-sponsored scientific sessions on vaccine-preventable diseases

Dear ESCMID Global attendees,

This year at the ESCMID Global Congress in Fira Gran Via, Barcelona, Spain, let's get ahead of infectious diseases together. Come along with us to uncover the unmet needs and patient-centric management approaches across vaccine-preventable diseases and much more at the following sessions:

Symposia

Why your influence counts: shaping adult vaccination policies and recommendations with a focus on herpes zoster

Sunday 28 April
12:15–13:15 CEST
Location: Hall P

ESCMID-appointed chair: Prof. Dan Barouch (USA)
Faculty: Prof. Giovanni Gabutti (Italy),
Prof. Thea Kølsen Fischer (Denmark),
Prof. Tino Schwarz (Germany),
Prof. Pierre Van Damme (Belgium)

Add event to your calendar

Rethinking the burden of RSV in Adults

Sunday 28 April
13:30–15:30 CEST
Location: Hall P

ESCMID-appointed chair: Dr Peng Wu (Hong Kong)
Faculty: Dr Alan Kaplan (Canada),
Dr Iván Sanz Muñoz (Spain),
Prof. Peter Openshaw (UK),
Prof. Caterina Rizzo (Italy)

Add event to your calendar

Innovation & Pipeline Theater sessions

Embracing Schrödinger’s cat in the rewriting of the infectious diseases narrative

Saturday 27 April
11:30–11:50 CEST
Location: Innovation Theater

Faculty: Dr Souha Kanj (Lebanon),
Dr Kamran Khan (Canada)

Add event to your calendar

How innovation fostered more than a decade of confidence in shingles prevention

Monday 29 April
13:00–13:20 CEST
Innovation Theater

Faculty: Dr Bakr Ahmed (GSK),
Dr Raunak Parikh (GSK)

GSK products will be discussed. Prescribing information is available from the GSK stand, at the symposium and via the ESCMID viewing platform.

Add event to your calendar

We look forward to welcoming you to these GSK-sponsored scientific sessions at ESCMID Global 2024.

Please do not forward.

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on +44(0)800 221 441 or UKSafety@gsk.com

Scientific dissemination is based on published and accessible data and has an informative/educational purpose. To this end, the data is presented faithfully reflecting scientific publications without any modification or addition. Its content is protected by copyright and may not be reproduced (photo, recording or 'screen prints'), nor disclosed or transmitted to any third party by any means, without the written authorization of GSK.

La divulgación científica está basada en datos publicados y accesibles y tiene una finalidad informativa/formativa. A tal efecto, los datos se presentan reflejando fielmente las publicaciones científicas sin ninguna modificación o añadido. Su contenido está protegido por derechos de autor y no puede ser reproducido (foto, grabación o 'impresiones de pantalla'), ni divulgado ni transmitido a ningún tercero por cualquier medio, sin la autorización escrita de GSK.

NP‑GBL‑AIS‑EML‑240002 | April 2024

You have received this email as a contact of ESCMID or one of its affiliated societies.
You can unsubscribe here.